CBIO - GLYCOMIMETICS INC
12.07
0.740 6.131%
Share volume: 159,573
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$11.33
0.74
0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-13-2025 | 05-14-2025 | 07-31-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 34.205 M | 24.419 M | 15.698 M | 11.091 M | 5.992 M | 157.433 M | 138.269 M | 240.293 M | |
| Current Assets | 33.267 M | 23.858 M | 15.646 M | 11.091 M | 5.992 M | 154.227 M | 134.563 M | 236.655 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 31.281 M | 22.386 M | 14.392 M | 10.720 M | 5.614 M | 152.645 M | 133.265 M | 213.192 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 193.000 K | 782.000 K | 846.000 K | |
| Other Assets | 937.520 K | 561.314 K | 52.320 K | 0.000 | 0.000 | 3.013 M | 2.924 M | 2.792 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 34.205 M | 24.419 M | 15.698 M | 11.091 M | 5.992 M | 157.433 M | 138.269 M | 240.293 M | |
| Total liabilities | 5.294 M | 4.356 M | 4.322 M | 5.778 M | 2.617 M | 18.179 M | 21.628 M | 37.281 M | |
| Total current liabilities | 5.294 M | 4.356 M | 4.322 M | 5.778 M | 2.617 M | 16.746 M | 20.304 M | 36.072 M | |
| Accounts Payable | 755.534 K | 950.763 K | 581.794 K | 329.304 K | 104.671 K | 6.831 M | 8.834 M | 10.137 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.433 M | 1.324 M | 1.209 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.433 M | 1.324 M | 1.209 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 28.911 M | 20.063 M | 11.376 M | 5.314 M | 3.375 M | 135.254 M | 112.641 M | 199.012 M | |
| Common stock | 496.133 M | 497.380 M | 498.518 M | 499.678 M | 500.083 M | 190.059 M | 192.053 M | 370.821 M | |
| Retained earnings | -467.222 M | -477.317 M | -487.142 M | -494.364 M | -496.708 M | -54.805 M | -79.412 M | -171.809 M |